1. Home
  2. ONMD vs MCRB Comparison

ONMD vs MCRB Comparison

Compare ONMD & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$0.59

Market Cap

42.1M

Sector

N/A

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

N/A

Current Price

$4.52

Market Cap

47.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
MCRB
Founded
2006
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.1M
47.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
ONMD
MCRB
Price
$0.59
$4.52
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
810.4K
58.2K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
N/A
EPS
N/A
N/A
Revenue
$1,359,000.00
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
111.35
N/A
52 Week Low
$0.49
$4.32
52 Week High
$4.22
$29.98

Technical Indicators

Market Signals
Indicator
ONMD
MCRB
Relative Strength Index (RSI) 43.19 39.41
Support Level $0.58 N/A
Resistance Level $0.83 $5.65
Average True Range (ATR) 0.07 0.34
MACD -0.01 0.05
Stochastic Oscillator 16.98 17.60

Price Performance

Historical Comparison
ONMD
MCRB

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: